Just In
- 1 hr ago Daily Horoscope, 18 April 2024: Libra Will See Financial Success, Relationship With Spouse Will Improve
- 12 hrs ago World's First Miss AI Pageant Announced, Know All About The Rise Of AI Beauty
- 15 hrs ago Summer Fashion: 6 Tips For Embracing Layering Styles To Keep It Cool And Stylish
- 15 hrs ago 7 Best Family-Friendly Tours In Iceland: Comfortable Packages For All Ages
Don't Miss
- Finance Infosys Q4 Results Preview: Muted Growth In Revenue Likely, Margins To See Gradual Rise
- Sports 'No regrets' says Pep Guardiola after Manchester City loss in Champions League
- Movies Ranam OTT Release Date And Platform: When And Where To Watch Vaibhav Reddy Starrer Movie Online
- News Delhi Capital's Captain Rishabh Pant Gathers Praise For His Wicketkeeping Skills, Stunning Catch
- Education SCCL Recruitment 2024; Application process, Selection criteria and more
- Automobiles Mahindra 3XO SUV Latest Teaser Reveals Connected Car Tech: All Details Here
- Technology OnePlus 13 Early Leak Hints at a Revamped Camera Island, and Fast Charging to Remain at 100W
- Travel From Coconut Breaking on Head to Men Dressing as Women: 12 Unique Indian Rituals Explored
Scientists To Develop Effective TB Vaccine
Know about a new vaccine against TB which is being developed by scientists.
There was a time when tuberculosis was considered no less than a cancer. However, with the advancement of medical technology, tuberculosis (TB) is like any other preventable and treatable disease now.
Making new strides in the treatment for TB, scientists have come up with a new effective vaccine against tuberculosis.
Tuberculosis (TB) is a disease that is caused by a bacterium - Mycobacterium tuberculosis (Mtb), transmitted by people infected with pulmonary (lung) TB who release Mtb into the air through coughing, sneezing or spitting.
According to the World Health Organization, there were about 9 million estimated new cases in 2013 and 1.5 million deaths. Over 90% of TB cases occur in low and middle income countries.
The airborne disease is becoming increasingly resistant to antibiotics, but despite 20 years of intense global efforts no effective vaccine has been developed, they said.
Recent efforts have focused on the response of conventional human T cells - a type of white blood cell essential to fighting off infection - to protein fragments found in Mycobacterium tuberculosis (Mtb), the bacteria that causes TB.
In the latest effort, researchers from the Universities of Southampton and Bangor in the UK, have shown that certain lipids - fatty substances essential to cell structure that are found in abundance in Mtb - could trigger an immune response from other, 'unconventional' types of T cells.
During the course of the study, the researchers showed that a group of lipids called mycolic acids, a major component of the Mtb cellular envelope could be key to determining an immune response.
The study further showed that the geometry, chemical make-up and movement of the mycolic acids' long lipid 'tails' when they are embedded in a type of human protein called CD1b determines the response of the body's unconventional T cells.
"This is an exciting discovery with potential therapeutic implications for TB patients. We have shown that synthetic lipids related to those in the cell wall of Mtb are selectively targeted by T-cells," said Salah Mansour, from the University of Southampton.
"Our findings could help drive advances in vaccine development through the intelligent design of the lipid components of future TB vaccines," said Mansour.
"This is a very exciting result of a collaboration between organic chemists and immunologists which could provide a real opportunity for improved protection against TB," Juma'a Al Dulayymi, from Bangor University added.
The study was recently published in the journal PNAS.
(With Agency Inputs)
- healthWorld Tuberculosis Day: Is Tuberculosis Contagious? How To Reduce TB Risk?
- healthWorld Tuberculosis Day: Types Of Tuberculosis
- wellnessCentury-Old TB Vaccine Could Be Effective Against Covid-19 And Other Infections: New Study
- wellnessTB Patients At Increased Risk Of All-Cause Mortality Even After Treatment: ICMR
- wellnessNational Institute For Research In Tuberculosis Developing Sputum-Free Tests For Diagnosing TB
- wellnessGovt To Launch Programme For Adopting, Providing Nutritional, Treatment Support To TB Patients
- wellnessSerum Institute Seeks Emergency Use Authorisation For Its rBCG Tuberculosis Vaccine
- wellnessWorld TB Day 2022: How Does Tuberculosis Affect Fertility? (Expert Article)
- babyWorld TB Day 2022: Tuberculosis In Babies And Children, Its Stages, Symptoms And Can It Be Prevented?
- disorders cureWorld TB Day 2022: FAQs On Tuberculosis Treatment And Its Link To COVID-19
- disorders cureWorld TB Day: Expert Article On Tuberculosis And Ayurveda
- nutritionWorld TB Day 2022: Foods To Consume And Avoid By Tuberculosis Patients